A new trading day began on Monday, with Lexeo Therapeutics Inc (NASDAQ: LXEO) stock price up 10.26% from the previous day of trading, before settling in for the closing price of $9.06. LXEO’s price has ranged from $1.45 to $10.38 over the past 52 weeks.
A company in the Healthcare sector has dropped its sales by -99.98% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 36.70%. With a float of $60.28 million, this company’s outstanding shares have now reached $72.99 million.
Lexeo Therapeutics Inc (LXEO) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Lexeo Therapeutics Inc is 17.40%, while institutional ownership is 75.64%. The most recent insider transaction that took place on Nov 18 ’25, was worth 10,447. In this transaction Chief Executive Officer of this company sold 1,127 shares at a rate of $9.27, taking the stock ownership to the 240,991 shares. Before that another transaction happened on Nov 18 ’25, when Company’s Chief Medical Officer sold 615 for $9.27, making the entire transaction worth $5,701. This insider now owns 72,646 shares in total.
Lexeo Therapeutics Inc (LXEO) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.78 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 36.70% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.91% during the next five years compared to -99.98% drop over the previous five years of trading.
Lexeo Therapeutics Inc (NASDAQ: LXEO) Trading Performance Indicators
Here are Lexeo Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.70, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -1.57 in one year’s time.
Technical Analysis of Lexeo Therapeutics Inc (LXEO)
Let’s dig in a bit further. During the last 5-days, its volume was 1.24 million. That was better than the volume of 0.79 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 67.47%.
During the past 100 days, Lexeo Therapeutics Inc’s (LXEO) raw stochastic average was set at 94.25%, which indicates a significant decrease from 96.68% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.61 in the past 14 days, which was higher than the 0.47 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.13, while its 200-day Moving Average is $4.88. However, in the short run, Lexeo Therapeutics Inc’s stock first resistance to watch stands at $10.34. Second resistance stands at $10.70. The third major resistance level sits at $11.33. If the price goes on to break the first support level at $9.36, it is likely to go to the next support level at $8.73. Assuming the price breaks the second support level, the third support level stands at $8.38.
Lexeo Therapeutics Inc (NASDAQ: LXEO) Key Stats
With a market capitalization of 729.15 million, the company has a total of 72,987K Shares Outstanding. Currently, annual sales are 0 K while annual income is -98,330 K. The company’s previous quarter sales were 0 K while its latest quarter income was -20,280 K.
